Search Results - Borislav Borissov

Gene therapy randomised clinical trials in Europe - a review paper of methodology and design by Krassimira Ilieva, Borislav Borissov, Mondher Toumi

Connect to this object online.

Patient-reported outcome claims in European and United States orphan drug approvals by Szymon Jarosławski, Pascal Auquier, Borislav Borissov, Claude Dussart, Mondher Toumi

Connect to this object online.

Cost-effectiveness of evolocumab in treatment of heterozygous familial hypercholesterolaemia in Bulgaria: measuring health benefit by effectively treated patient-years* by Borislav Borissov, Michael Urbich, Boryana Georgieva, Svetoslav Tsenov, Guillermo Villa

Connect to this object online.

Low rates of patient-reported outcome claims for orphan drugs approved by the us food and drug administration by Szymon Jarosławski, Pascal Auquier, Borislav Borissov, Claude Dussart, Mondher Toumi

Connect to this object online.

Reinforcing Collaboration and Harmonization to Unlock the Potentials of Advanced Therapy Medical Products: Future Efforts Are Awaited From Manufacturers and Decision-Makers by Tingting Qiu, Shuyao Liang, Yitong Wang, Claude Dussart, Borislav Borissov, Mondher Toumi

Connect to this object online.

Cost-Effectiveness Analysis of Innovative Therapies for Patients with Non-Alcoholic Fatty Liver Disease by Michal Pochopien, Jakub Wladyslaw Dziedzic, Samuel Aballea, Emilie Clay, Iwona Zerda, Mondher Toumi, Borislav Borissov

Connect to this object online.

Why "American Patients First" is likely to raise drug prices outside of the United States by Monique Dabbous, Cyprien Milea, Steven Simoens, Clement François, Claude Dussart, Lylia Chachoua, Borislav Borissov, Mondher Toumi

Connect to this object online.